Back to RLMD

CITADEL ADVISORS LLC → RLMD

CITADEL ADVISORS LLC RLMD Position History

Relmada Therapeutics, Inc. • Healthcare

Quarters held
7
Latest value
$66K
Q3 2026
Peak value
$7.3M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$7.3M
Q2 2026$754K
Q2 2026$7.3M
Q2 2026$754K
Q3 2026$187K
Q3 2026$1.7M
Q3 2026$66K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$66K17.4K——
Q3 2026$1.7M442.1K——
Q3 2026$187K49.7K——
Q2 2026$754K109.0K——
Q2 2026$7.3M1.06M——
Q2 2026$754K109.0K——
Q2 2026$7.3M1.06M——

Other funds holding RLMD

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B